This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Dompe U.S. Inc., a foreign-owned pharmaceutical manufacturer, under the GSA Pharmaceuticals and Drugs schedule (FSS-61-IB). The order is for the supply of Oxervate (cenegermin-bkbj) 0.002% ophthalmic solution, a medication used to treat neurotrophic keratitis. The $39,774.12 order was placed by the VA's Veterans Integrated Service Network 5 to fulfill medication needs at VA facilities. Dompe U.S. Inc. has received multiple similar orders against this GSA schedule, as well as a $2.4 million blanket purchase agreement and a $5 million FSS schedule contract with the VA specifically for Oxervate and other pharmaceutical products. There is no set-aside designation for this award.
Generated 4/2/25, 10:17 AM